Clinical Trial Update: Efficacy of Nanodropper-mediated Topical Anesthetic [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the efficacy of a Nanodropper-delivered topical anesthetic for corneal diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Diseases

Drugs mentioned

• Topical anesthetic (Nanodropper-delivered)

Snippet

Sponsor: Columbia University | Conditions: Corneal Diseases, Effectiveness of Microdrops | Phase 4 | Status: COMPLETED